GRDX Q1 2026 Earnings PreRevenue Stage with Widening Losses XNET Q3 2024 Earnings EPS of 008 Highlights Operational Control Amid Sparse Disclosure Sensei Biotherapeutics SNSE Q1 2026 Earnings Massive EPS Miss Overshadowed by Upbeat Sentiment TRIN Q1 2026 Earnings Small EPS Beat Amid Lack of Revenue Data Stock Edges Lower Immunome Inc IMNM Q1 2026 Earnings SmallerThanExpected Loss as Biotech Advances Pipeline APYX Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid Revenue Uncertainty